Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

First launch for Quadramet

May 22, 1997

NMDA antagonist/opiate combination provides superior analgesia to morphine alone

May 22, 1997

Pfizer reports prodrugs of NMDA antagonist

May 22, 1997

Glaxo Wellcome describes optically active pyrimidine useful as analgesic and anticonvulsant

May 22, 1997

Atypical neuroleptics from Merck KGaA

May 22, 1997

NIH funds Cognetix's research on antiseizure drug

May 21, 1997

Serzone superior to Prozac in the treatment of sleep disturbances in depressed patients

May 21, 1997

Excitatory amino acid antagonists disclosed by Glaxo Wellcome

May 21, 1997

Mitsubishi/Takeda codevelop new drug for AD

May 20, 1997

ADIR discloses compounds with high affinity for human D3 receptors

May 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...